• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受长期泼尼松治疗的免疫疾病患者中泼尼松龙的血浆蛋白结合参数。

Plasma protein-binding parameters of prednisolone in immune disease patients receiving long-term prednisone therapy.

作者信息

Wagner J G, Wexler D, Ağabeyoğlu I T, Bergstrom R F, Sakmar E, Kay D R

出版信息

J Lab Clin Med. 1981 Apr;97(4):487-501.

PMID:7205057
Abstract

Prednisone and prednisolone bind in plasma to albumin and transcortin. In am attempt to determine whether prednisone side effects and/or type of disease correlated with prednisolone plasma protein binding, multiple plasma samples from 17 patients (three asthma, eight SLE, three RA, two PSS, one PAN) receiving long-term prednisone therapy were monitored during an interval between two prednisone doses. Prednisolone plasma protein binding was nonlinear and exhibited large intrapatient and interpatient variability. For the group, mean association constants of the prednisolone-albumin complex and the prednisolone-transcortin complex were 2.3 X 10(3) M-1 and 2.9 X 10(7) M-1, with coefficients of variation of 82% and 127%, respectively. SLE patients tended to have lower mean prednisolone association constants for albumin and transcortin than did other patients. The presence of corticosteroid side effects did not correlate with prednisolone plasma protein-binding parameters. The wide range of prednisolone free fraction noted in plasma from patients who achieved comparable total prednisolone plasma concentrations implies that administration of a uniform prednisone dose will not lead to a predictable clinical response.

摘要

泼尼松和泼尼松龙在血浆中与白蛋白和皮质激素转运蛋白结合。为了确定泼尼松的副作用和/或疾病类型是否与泼尼松龙的血浆蛋白结合相关,在17例接受长期泼尼松治疗的患者(3例哮喘、8例系统性红斑狼疮、3例类风湿关节炎、2例进行性系统性硬化症、1例结节性多动脉炎)的两个泼尼松剂量间隔期间,对多个血浆样本进行了监测。泼尼松龙的血浆蛋白结合呈非线性,且在患者内和患者间存在很大差异。对于该组患者,泼尼松龙 - 白蛋白复合物和泼尼松龙 - 皮质激素转运蛋白复合物的平均缔合常数分别为2.3×10³ M⁻¹和2.9×10⁷ M⁻¹,变异系数分别为82%和127%。系统性红斑狼疮患者的泼尼松龙与白蛋白和皮质激素转运蛋白的平均缔合常数往往低于其他患者。皮质类固醇副作用的存在与泼尼松龙血浆蛋白结合参数无关。在总泼尼松龙血浆浓度相当的患者血浆中观察到的泼尼松龙游离分数范围很广,这意味着给予统一的泼尼松剂量不会导致可预测的临床反应。

相似文献

1
Plasma protein-binding parameters of prednisolone in immune disease patients receiving long-term prednisone therapy.接受长期泼尼松治疗的免疫疾病患者中泼尼松龙的血浆蛋白结合参数。
J Lab Clin Med. 1981 Apr;97(4):487-501.
2
Simultaneous determination of prednisolone, prednisone, cortisol, and cortisone in plasma by GC-MS: estimating unbound prednisolone concentration in patients with nephrotic syndrome during oral prednisolone therapy.
J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Jul 15;870(2):164-9. doi: 10.1016/j.jchromb.2008.03.003. Epub 2008 Mar 8.
3
Pharmacokinetics of prednisone and prednisolone at steady state in the rabbit.泼尼松和泼尼松龙在兔体内稳态时的药代动力学
Drug Metab Dispos. 1985 Jul-Aug;13(4):503-9.
4
Prednisone for chronic active hepatitis: pharmacokinetics and serum binding in patients with chronic active hepatitis and steroid major side effects.
J Clin Gastroenterol. 1984 Aug;6(4):331-5.
5
Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome.肾病综合征患者泼尼松龙的血浆蛋白结合发生改变。
Am J Kidney Dis. 1984 Mar;3(5):339-48. doi: 10.1016/s0272-6386(84)80081-5.
6
Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia.急性淋巴细胞白血病患儿中泼尼松龙的群体药代动力学
Cancer Chemother Pharmacol. 2003 Jun;51(6):465-73. doi: 10.1007/s00280-003-0602-3. Epub 2003 Apr 16.
7
Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding.肝脏疾病中的皮质类固醇:关于泼尼松向泼尼松龙的生物转化及血浆蛋白结合的研究
Gut. 1972 Sep;13(9):690-6. doi: 10.1136/gut.13.9.690.
8
Dose dependent pharmacokinetics of prednisone and prednisolone in man.泼尼松和泼尼松龙在人体中的剂量依赖性药代动力学。
J Pharmacokinet Biopharm. 1981 Aug;9(4):389-417. doi: 10.1007/BF01060885.
9
Prednisolone concentrations in cerebrospinal fluid after oral prednisone. Preliminary data.
Rev Rhum Engl Ed. 1997 May;64(5):301-4.
10
Altered metabolism and decreased efficacy of prednisolone and prednisone in patients with hyperthyroidism.
Clin Pharmacol Ther. 1988 Nov;44(5):510-21. doi: 10.1038/clpt.1988.188.

引用本文的文献

1
Pharmacokinetics and Pharmacodynamics of Systemic Corticosteroids in Autoimmune and Inflammatory Diseases: A Review of Current Evidence.全身性皮质类固醇在自身免疫和炎症性疾病中的药代动力学和药效学:当前证据综述。
Clin Pharmacokinet. 2024 Sep;63(9):1251-1270. doi: 10.1007/s40262-024-01419-7. Epub 2024 Sep 12.
2
The binding of prednisolone in human serum and to recrystallized human albumin in vitro.泼尼松龙在人血清中的结合以及在体外与重结晶人白蛋白的结合。
Br J Clin Pharmacol. 1982 Nov;14(5):667-72. doi: 10.1111/j.1365-2125.1982.tb04954.x.
3
Prednisolone inhibits phagocytosis by polymorphonuclear leucocytes via steroid receptor mediated events.
泼尼松龙通过类固醇受体介导的过程抑制多形核白细胞的吞噬作用。
Ann Rheum Dis. 1983 Feb;42(1):56-62. doi: 10.1136/ard.42.1.56.
4
Estimation of transcortin concentration by measurements of plasma protein-binding of prednisolone and by electroimmunodiffusion.通过测量泼尼松龙的血浆蛋白结合率和免疫电泳法估算皮质素转运蛋白浓度。
Br J Clin Pharmacol. 1982 Feb;13(2):245-9. doi: 10.1111/j.1365-2125.1982.tb01370.x.
5
Pharmacokinetic interaction of contraceptive steroids with prednisone and prednisolone.甾体避孕药与泼尼松和泼尼松龙的药代动力学相互作用。
Eur J Clin Pharmacol. 1984;26(4):505-11. doi: 10.1007/BF00542149.
6
Pharmacokinetics of prednisone and its metabolite prednisolone in children with nephrotic syndrome during the active phase and in remission.泼尼松及其代谢产物泼尼松龙在肾病综合征患儿活动期和缓解期的药代动力学
Br J Clin Pharmacol. 1984 Apr;17(4):423-31. doi: 10.1111/j.1365-2125.1984.tb02367.x.
7
The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone.泼尼松的剂量依赖性全身可用性:隔日服用泼尼松生物效应降低的一个原因。
Br J Clin Pharmacol. 1986 Feb;21(2):183-9. doi: 10.1111/j.1365-2125.1986.tb05173.x.